Search research articles
Contact Us
Filters
Showing results (91-100 of 152) with videos related to
Page
of 16
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 18, 2020
Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
Richard L Wahl, Panithaya Chareonthaitawee, Bonnie Clarke, et al.
Cancer Medicine
|
January 10, 2014
Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer
Gary A Ulaner, Anne Eaton, Patrick G Morris, et al.
Medical Physics
|
April 7, 2022
High-resolution and high-sensitivity PET for quantitative molecular imaging of the monoaminergic nuclei: A GATE simulation study
Zipai Wang, Xinjie Cao, Andy LaBella, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 15, 2015
Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype
Brittany Z Dashevsky, Debra A Goldman, Molly Parsons, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 22, 2015
Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma
Molly P Hogan, Debra A Goldman, Brittany Dashevsky, et al.
European Journal of Radiology
|
May 11, 2016
Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0
Waleed Shady, Sirish Kishore, Somali Gavane, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 3, 2017
Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer
Christopher C Riedl, Katja Pinker, Gary A Ulaner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 18, 2017
First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using <sup>89</sup>Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
Gary A Ulaner, Serge K Lyashchenko, Christopher Riedl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 10, 2023
Summary: SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16α-[<sup>18</sup>F]Fluoro-17β-Estradiol PET
David Mankoff, Soňa Balogová, Lisa Dunnwald, et al.
Tomography (Ann Arbor, Mich.)
|
August 25, 2023
Detection of Biochemically Recurrent Prostate Cancer with [<sup>18</sup>F]DCFPyL PET/CT: An Updated Systematic Review and Meta-Analysis with a Focus on Correlations with Serum Prostate-Specific Antigen Parameters
Mohammad S Sadaghiani, Sara Sheikhbahaei, Abdullah Al-Zaghal, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 152) with videos related to
Sort By:
Page
of 16
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 18, 2020
Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
Richard L Wahl, Panithaya Chareonthaitawee, Bonnie Clarke, et al.
Cancer Medicine
|
January 10, 2014
Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer
Gary A Ulaner, Anne Eaton, Patrick G Morris, et al.
Medical Physics
|
April 7, 2022
High-resolution and high-sensitivity PET for quantitative molecular imaging of the monoaminergic nuclei: A GATE simulation study
Zipai Wang, Xinjie Cao, Andy LaBella, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 15, 2015
Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype
Brittany Z Dashevsky, Debra A Goldman, Molly Parsons, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 22, 2015
Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma
Molly P Hogan, Debra A Goldman, Brittany Dashevsky, et al.
European Journal of Radiology
|
May 11, 2016
Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0
Waleed Shady, Sirish Kishore, Somali Gavane, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 3, 2017
Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer
Christopher C Riedl, Katja Pinker, Gary A Ulaner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 18, 2017
First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using <sup>89</sup>Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
Gary A Ulaner, Serge K Lyashchenko, Christopher Riedl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 10, 2023
Summary: SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16α-[<sup>18</sup>F]Fluoro-17β-Estradiol PET
David Mankoff, Soňa Balogová, Lisa Dunnwald, et al.
Tomography (Ann Arbor, Mich.)
|
August 25, 2023
Detection of Biochemically Recurrent Prostate Cancer with [<sup>18</sup>F]DCFPyL PET/CT: An Updated Systematic Review and Meta-Analysis with a Focus on Correlations with Serum Prostate-Specific Antigen Parameters
Mohammad S Sadaghiani, Sara Sheikhbahaei, Abdullah Al-Zaghal, et al.
Page
of 16